Aging

KHN’s ‘What the Health?’: Our 200th Episode!

The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.

Is Your Living Room the Future of Hospital Care?

In the latest sign that in-home acute care is catching on, two big players — Kaiser Permanente and the Mayo Clinic — announced plans to collectively invest $100 million into the company Medically Home to help scale up their programs.

The Vulnerable Homebound Are Left Behind on Vaccination

Even as the nation has moved on to vaccinating everyone 16 and older, the vast majority of people homebound due to frailty or age — and among the most vulnerable to covid’s devastation — have not yet been vaccinated. California offers a sharp lens on the challenges.